soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 reduced the risk of clinically important kidney and death from (CV) causes in patients with type 2 diabetes (T2D) and CKD ca. #ERA24 🇸🇪 #Nephpearls https://www.nejm .org/doi/full/10.1056/NEJMoa2403347 Forecasting Trial Milestones: A Predictive

I filed a patent to use GLP-1 as an anxiolytic, but really, the mice were just sick patft.uspto.gov/netacgi/nph-Pa The CNS GLP-1 food intake #weightloss #obesity story has turned out to be far more scientifically interesting and clinically relevant than I first appreciated

doi:10.1016/S0891-5849(99)00090-8.

Ask a close friend, companion, spouse, or relative to learn how to administer vitamin B12 shots, or at least hold a mirror for you while you give yourself the injection, and rub out the pain afterwards to prevent bruising and other painful side effects

Goals and Objectives of the Program The primary goals of the Wegovy PAP are to: Provide access to Wegovy for eligible patients who cannot afford the medication